Is Alastin available in Japan now?

Yes, Galderma has officially launched Alastin across Japan and key Asia-Pacific markets. The launch capitalizes on rising aesthetic procedure volume and GLP-1 adoption trends driving patient demand in the region.

What is Alastin skincare used for in med spas?

Alastin specializes in restorative peptide and enzyme-based formulations designed for pre-procedure prep and post-treatment recovery. Practices use it as a high-margin skincare add-on alongside injectables like Botox and Juvéderm to capture additional revenue from patients.

Why is Galderma expanding Alastin to Asia-Pacific?

Galderma is expanding into Asia-Pacific to capitalize on accelerating aesthetic spending, rising procedure volumes, and preventive anti-aging trends driven by GLP-1 adoption. The move allows the company to deepen wallet share by offering the full patient journey from pre-care through post-treatment recovery.

Can I bundle Alastin with Botox and Juvéderm at my practice?

Yes, Alastin's launch complements Galderma's core injectables portfolio and is specifically positioned to work alongside Botox and Juvéderm. This bundling strategy helps practices maximize patient lifetime value and margin by offering comprehensive pre- and post-procedure skincare solutions.

What markets in Asia-Pacific are getting Alastin?

Galderma has launched Alastin across Japan and key Asia-Pacific markets, though specific country-by-country rollout details were not disclosed. The expansion targets high-growth aesthetic markets where procedure demand and preventive anti-aging spending are accelerating.

Business & M&A

Galderma Launches Alastin in Japan, Asia-Pacific Markets

Skincare brand enters region as aesthetics demand accelerates across Asia.

By Evan at Inside MedSpa · Jul 21, 2026

Galderma has launched Alastin across Japan and key Asia-Pacific markets, marking a significant regional footprint expansion for the Swiss skincare brand. The move capitalizes on rising aesthetic procedure volume in the region, where GLP-1 adoption and preventive anti-aging trends are driving patient demand.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/galderma-alastin-asia-pacific-expansion/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Galderma Launches Alastin in Japan, Asia-Pacific Markets

Share

Discussion

Leave a comment

By the time it's news, it's too late.